Section Arrow
Quote
BLCO.NYSE
- Bausch + Lomb Corp
Quotes are at least 15-min delayed:2025/11/15 01:11 EST
Regular Hours
Last
 15.6
-0.09 (-0.57%)
Day High 
15.87 
Prev. Close
15.69 
1-M High
16.81 
Volume 
434.84K 
Bid
13
Ask
15.88
Day Low
15.24 
Open
15.58 
1-M Low
14.6 
Market Cap 
5.56B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 15.67 
20-SMA 15.56 
50-SMA 15.2 
52-W High 20.71 
52-W Low 10.45 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-0.86/1.05
Enterprise Value
10.30B
Balance Sheet
Book Value Per Share
18.15
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
4.79B
Operating Revenue Per Share
11.21
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MLSSMilestone Scientific0.33-0.0497-13.09%-- 
AVTRAvantor11.38-0.32-2.74%11.55PE
BAXBaxter International18.47-0.23-1.23%140.32PE
HOLXHologic74.15-0.11-0.15%30.81PE
XRAYDENTSPLY SIRONA10.52-0.43-3.93%-- 
Quotes are at least 15-min delayed：2025/11/15 01:11 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.